Deepak Korgaonkar

The Nifty Midcap Select index hit a new high of 14,223.90, soaring 2% and surpassing its previous high of 14,118 touched on December 1, 2025.

The Nifty Pharma index was quoting higher for the fifth straight trading day, surging 3.8 per cent during the period, as against 0.37 per cent gain in Nifty 50.

At 11:32 AM on Wednesday, Vedanta quoted 3 per cent higher at ₹312.65 on the BSE, as compared to a 0.26 per cent rise in the BSE Sensex.

The Cabinet approved the Emergency Credit Line Guarantee Scheme (ECLGS) 5.0 to provide additional credit support to businesses facing liquidity stress due to the West Asia situation.

Q4 execution was impacted by ₹5,000 crore revenue slippage due to supply chain disruptions in the Middle East and delays in water projects, indicating near-term execution headwinds.

Omax Autos was locked at the 20% upper circuit at ₹186.90 backed by heavy volumes, and the stock has zoomed per cent in the past two trading days.

The share of individual investors (retail and High Net Worth Individual (HNI) combined) in companies listed on the NSE declined to a 5-year low of 9.11 per cent as on March 31, 2026.

The Nifty India Defence index hit an intra-day high of 9,093.20, up 1.3 per cent on the NSE in intra-day deals, and was inching towards its 52-week high of 9,159.55 touched on June 24, 2025.

According to BSE bulk deal data, the investor Vallabh Roopchand Bhanshali purchased 2 million equity shares of Sunflag Iron & Steel for ₹60 crore.

Till 02:53 PM on Monday, as many as 52.52 million equity shares representing 2.3% of total equity of Adani Ports changed hands on the NSE and BSE.

In the past one month, the market price of BHEL has appreciated by 62 per cent, as compared to 5 per cent rise in the BSE Sensex.

JM Financial Institutional Securities maintains 'Buy' rating on HAL with a target price of ₹4,875.

Laurus Labs is now getting the benefit of the same as the CDMO quarterly run rate has gone up from ₹220-250 crore to ₹450-500 crore in two years, believe analysts.

Analysts at Citi Research has set a target price of ₹14 for Voda Idea stock, but flag limited AGR relief and intensified competition as key risks.

Among 1,262 stocks from the BSE Smallcap index, over half, or 734 stocks, outperformed in April by recording more than 20 per cent return, data shows.

Supported by the Sun Pharma's proven record of strong cash flows, analysts remain confident in gradual deleveraging over time.

MTAR, as Bloom's key supplier of critical hot box assemblies (commanding 60-70 per cent wallet share), is not merely a beneficiary of this theme but an irreplaceable enabler of it, MOFSL said.

Vedanta remains firm on its deleveraging plans, and going forward, higher cash flows will support both its expansion plans and deleveraging efforts.

Adani Power reported strong PAT generation in Q4, driven by robust operating profitability and lower tax expenses.

The share price of Swiggy is quoting lower for a fifth straight trading day, falling 7.5 per cent during the period